T. Rowe Price Associates’s Enveric Biosciences ENVB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-143	Closed	-$35K	–	2967
2022 Q1	$35K	Sell	143 -42	-23%	-$10.3K	﹤0.01%	2934
2021 Q4	$129K	Buy	185 +114	+161%	+$79.5K	﹤0.01%	2833
2021 Q3	$110K	Buy	+71	New	+$110K	﹤0.01%	2820